RecruitingPhase 2NCT06570798
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
Sponsor: Amgen
Cleveland, OH · +15 more sites
6 recruiting lupus studies with a site in Cleveland, OH.
Sponsor: Amgen
Cleveland, OH · +15 more sites
Sponsor: AstraZeneca
Cleveland, OH · +14 more sites
Sponsor: AstraZeneca
Cincinnati, OH · Cleveland, OH · Columbus, OH · +19 more sites
Sponsor: Children's Hospital Medical Center, Cincinnati
Akron, OH · Cincinnati, OH · Cleveland, OH · +16 more sites
Sponsor: Fate Therapeutics
Cleveland, OH · +15 more sites
Sponsor: Lupus Research Alliance
Cleveland, OH · +18 more sites
Listings come from ClinicalTrials.gov and are provided for information only. Always confirm eligibility with the study team and talk with your doctor before making decisions about your care.